LOTUS BAKERIES 9 940.000 € (+0,40 %) VASTNED 29.700 € (+0,34 %) INCLUSIO SA/NV 17.600 € (+0,28 %) TUBIZE-FIN 219.500 € (+0,69 %) UCB 264.500 € (-1,23 %) ARGENX SE 647.200 € (+0,22 %) RETAIL ESTATES 68.300 € (+1,79 %) WDP 23.480 € (+0,77 %) SOLVAY 26.700 € (-0,15 %) ASCENCIO 49.800 € (+2,26 %) VGP 86.900 € (0,00 %) EXMAR 10.140 € (+1,00 %) UMICORE 16.350 € (-1,39 %) NYXOAH 3.040 € (+13,64 %) EKOPAK 4.600 € (-5,93 %) QUESTFOR GR-PRICAF 2.810 € (-1,40 %) WERELDHAVE BELGIUM 55.000 € (+0,73 %) JENSEN-GROUP 66.200 € (-1,19 %) SIPEF 97.800 € (+0,41 %) SOFINA 214.200 € (-0,28 %) WHAT''S COOKING GP 142.000 € (+0,71 %) ONWARD MEDICAL 3.235 € (-5,27 %) D'IETEREN GROUP 161.700 € (-1,76 %) CAMPINE 198.000 € (+1,54 %) TINC 11.720 € (+0,69 %) KBC 108.700 € (-1,05 %) DEME GROUP 190.000 € (-0,52 %) AB INBEV 61.500 € (+1,25 %) MELEXIS 54.050 € (-1,46 %) DECEUNINCK 2.045 € (-0,97 %) FAGRON 22.100 € (+1,38 %) RECTICEL 9.620 € (-2,04 %) CENERGY 19.240 € (-1,33 %) AZELIS GROUP 8.935 € (+2,00 %) COFINIMMO 83.900 € (+0,66 %) SYENSQO 47.540 € (-3,59 %) KBC ANCORA 72.500 € (-0,68 %) EVS BROADC.EQUIPM. 33.750 € (-1,46 %) GIMV 46.200 € (+1,09 %) FLUXYS BELGIUM D 20.900 € (-2,79 %) PROXIMUS 6.985 € (-1,48 %) KINEPOLIS GROUP 26.600 € (+0,38 %) ACKERMANS V.HAAREN 272.200 € (+0,37 %) MONTEA 67.400 € (+0,30 %) ELIA GROUP 135.000 € (+0,75 %) SHURGARD 25.750 € (+0,39 %) BEKAERT 39.750 € (-2,09 %) ONTEX GROUP 3.345 € (+0,60 %) ENERGYVISION 12.500 € (+0,24 %) COLRUYT 35.660 € (+0,96 %) VIOHALCO 12.780 € (-3,18 %) ORANGE BELGIUM 20.500 € (0,00 %) BARCO 9.315 € (-2,10 %) CFE 10.500 € (0,00 %) IMMOBEL 21.800 € (+1,40 %) SOLVAC NOM(RETAIL) 68.400 € (+0,88 %) TESSENDERLO 20.500 € (-0,73 %) XIOR 27.400 € (+1,86 %) HOME INVEST BE. 19.100 € (+3,35 %) ECONOCOM GROUP 1.400 € (-1,13 %)
SANOFI 82.580 € (-0,35 %)
ID LOGISTICS GROUP 325.500 € (-2,54 %)
EVERGREEN 0.170 € (+129,05 %)
VALEO 10.400 € (-4,98 %)
ADYEN 845.200 € (-2,14 %)
ING GROEP N.V. 22.945 € (-1,25 %)
WOLTERS KLUWER 65.320 € (+0,37 %)
KERING 265.250 € (+0,78 %)
KPN KON 4.848 € (+1,66 %)
STELLANTIS NV 6.574 € (+3,97 %)
Vusion 108.700 € (-2,16 %)
ALLFUNDS GROUP 8.600 € (+0,58 %)
THEON INTERNAT 34.000 € (+1,49 %)
ROBERTET 815.000 € (+0,25 %)
ASML HOLDING 1 161.000 € (-2,24 %)
NSE 49.500 € (-0,80 %)
TOUAX 3.940 € (0,00 %)
BNP PARIBAS ACT.A 83.300 € (-2,44 %)
FORVIA 9.944 € (-2,27 %)
KALRAY 3.405 € (-2,71 %)
POXEL 0.281 € (-11,91 %)
EXAIL TECHNOLOGIES 133.000 € (+1,53 %)
RUBIS 35.060 € (+0,57 %)
ORANGE 17.890 € (+1,22 %)
ASR NEDERLAND 60.920 € (+0,33 %)
AIRBUS 165.140 € (-1,64 %)
BOIRON 28.000 € (+1,08 %)
PLANISWARE 14.580 € (-0,82 %)
ARCELORMITTAL SA 45.660 € (-2,14 %)
PHILIPS KON 23.580 € (-0,08 %)
NOVACYT 0.373 € (-1,84 %)
ENGIE 28.970 € (+2,01 %)
STMICROELECTRONICS 29.085 € (-2,84 %)
BE SEMICONDUCTOR 190.150 € (+1,39 %)
WORLDLINE 0.289 € (+6,10 %)
DSM FIRMENICH AG 61.420 € (+1,12 %)
EIFFAGE 135.700 € (-0,33 %)
HEINEKEN HOLDING 62.850 € (+0,24 %)
SCHNEIDER ELECTRIC 236.150 € (-1,58 %)
2CRSI 28.700 € (-2,21 %)
FNAC DARTY 35.250 € (0,00 %)
SHELL PLC 40.605 € (+2,73 %)
LATECOERE 0.021 € (+5,05 %)
ALUMEXX N.V. 1.440 € (-1,37 %)
VINCI 131.600 € (-0,75 %)
NANOBIOTIX 27.400 € (-5,35 %)
PROSUS 40.020 € (-1,26 %)
FRANCAISE ENERGIE 41.050 € (+7,74 %)
SAFRAN 287.300 € (-1,14 %)
INPOST 15.130 € (+0,07 %)
AALBERTS NV 30.020 € (-2,09 %)
NEOVACS 0.001 € (-16,67 %)
ALPES (COMPAGNIE) 24.700 € (+1,23 %)
EURONEXT 143.300 € (+2,07 %)
MAUREL ET PROM 10.920 € (+7,48 %)
AHOLD DEL 41.730 € (+1,29 %)
ALTAMIR 24.600 € (0,00 %)
LHYFE 2.490 € (-0,20 %)
TOTALENERGIES 79.420 € (+2,40 %)
ABC ARBITRAGE 5.300 € (-0,93 %) News Réglementées
|
26/03/2026 09:00
Original-Research: ZEAL Network SE (von NuWays AG): BUYOriginal-Research: ZEAL Network SE - from NuWays AG Classification of NuWays AG to ZEAL Network SE
Marketing unlocks more growth potential, chg. Q4 results, the FY’26 guidance and the new mid-term ambition all point to the same conclusion: ZEAL has more near-term growth potential than previously anticipated, unlockable through additional marketing spend while keeping EBITDA margins around 30%. This is the key takeaway from the release and fully supports our BUY recommendation. ZEAL exceeded the implied Q4 guidance upper range on both sales (€ 55.9m, vs guided € 52.4m) and EBITDA (€ 14.7m, vs. guided € 13.9m; see p. 2 for details). We attribute this to strong marketing efficiency, as the jackpot environment offered no support (0 jackpots in Q4). Cost per lead remained roughly stable at c. € 46 compared to other low jackpot phases (e.g. 9M’25 or FY’23), despite costlier in-house raffle ads for Traumhausverlosung (eNuW), pointing to continued capacity to deploy higher spend efficiently. Importantly, higher marketing spend should be value accretive, in our view, as it enables ZEAL to acquire customers early in the ongoing online migration and further consolidate its leadership. Marketing spend remains disciplined by internal KPIs such as a 2-3 year payback period and customer lifetime values. With c. 60% of billings subscription based, each newly acquired customer strengthens the recurring revenue base and supports meaningful margin upside once growth spending normalises. The FY’26 guidance implies c. 17% yoy sales growth at mid-point, well ahead of consensus (11% yoy). Growth should be supported by the structural shift of lottery demand into online channels, new partnerships and a broader acquisition mix beyond Google and Meta. The EBITDA guidance conservatively reflects these growth investments and still points to a healthy margin of c. 27-30% (new eNuW: 28.8%). More importantly, the new mid-term ambition suggests that mid-teens growth should extend into 2029e, supported by the same structural tailwinds, the ramp-up of Traumhausverlosung and Games, as well as further expansion initiatives that have yet to be disclosed. ZEAL’s earnings quality remains excellent. FY’25 FCF of € 59.5m exceeded net profit of € 41.7m by a wide margin (143% conversion), reflecting non-cash PPA amortisation (€ 7.4m) and favourable working capital effects. At the same time, net cash of c. € 31m at year-end leaves room for additional capital returns, with further share buybacks as potential catalyst in 2026e (eNuW). In sum, very few European quality growth names combine mid-teens mid-term sales growth, >30% EBITDA margins and further margin upside. Fewer still are available at only 22x PPA-adjusted 2026e earnings, in our view. That is why Zeal remains a high-conviction BUY, PT raised to € 80 (old: € 67), based on DCF. You can download the research here: zeal-network-se-2026-03-26-longupdate-en-316f1 For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse. ++++++++++ The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 2298106 26.03.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière